Helminth therapies: Translating the unknown unknowns to known knowns
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The use of live helminth infections is currently in clinical trials as a novel approach for the treatment of a range of allergic and autoimmune diseases. This rapid progression from observational studies some 20 years ago to helminth clinical trials can be attributed to huge advances in not just pre-clinical and clinical evidence, pertaining to the efficacy of these parasites in unrelated diseases, but also a greater understanding of the complex immunological mechanisms that underpin these effects. Helminths have exerted significant evolutionary selective pressures on the host immune genome or "immunome". Studies on helminths were pivotal in a paradigm shift in immunology with recent discoveries of a number of novel immune cell populations. Critically, these new discoveries highlight the need to further understand the underlying mechanism behind the desirable therapeutic effects that helminths offer. With these unknown unknowns there is the distinct possibility that a true, fundamental modus operandi for helminth therapy will arrive long after it has been established in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831 · cited 1×
“Thus the absence of helminths in developed societies is argued to contribute to the profound increase in the incidence of allergic and autoimmune diseases observed during the last few decades (Yazdanbakhsh et al., 2002; Dunne and Cooke, 2005; Allen and Maizels, 2011).”
BackgroundPrenatal exposure to the Dutch famine and disease in later life: An overview
Painter, R. C., Roseboom, T. J., & Bleker, O. P. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.04.005 · Cited by 784
Trichuris suis therapy in Crohn’s disease
Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R., & Weinstock, J. V. (2005) · Gut · doi:10.1136/gut.2004.041749 · Cited by 762
Toll-like receptors — taking an evolutionary approach
Leulier, F., & Lemaitre, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2303 · Cited by 581 · cited 2×
“…investigated Toll-like receptor (TLR) family of innate immune receptors may have had an ancestral function in its development and thus, during evolutionary selection, have been co-opted to play a role in immunity to pathogens in multiple species of the animal kingdom (Leulier and Lemaitre, 2008).”
BackgroundExperimental hookworm infection: a randomized placebo-controlled trial in asthma
Feary, J. R., Venn, A. J., Mortimer, K., Brown, A. P., Hooi, D., Falcone, F. H., Pritchard, D. I., & Britton, J. R. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03433.x · Cited by 188
Cited by
The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation
Zaiss, M. M., Rapin, A., Lebon, L., Dubey, L. K., Mosconi, I., Sarter, K., Piersigilli, A., Menin, L., Walker, A. W., Rougemont, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.012 · Cited by 437
“Consequently, live helminths are currently employed in at least 15 clinical trials in efforts to alleviate allergic and autoimmune disorders (Khan and Fallon, 2013).”
BackgroundSchistosoma “Eggs-Iting” the Host: Granuloma Formation and Egg Excretion
Schwartz, C., & Fallon, P. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02492 · Cited by 235
“We previously posited on helminth immunobiology that despite such discoveries, there are many unknown unknowns yet to be not only identified but also to be experimentally investigated (171).”
BackgroundSelf-citationMaruszewska-Cheruiyot, M., Donskow-Łysoniewska, K., & Doligalska, M. (2018) · Helminthologia · doi:10.1515/helm-2017-0048 · Cited by 38
Helminth Induced Immunoregulation and Novel Therapeutic Avenue of Allergy
Ayelign, B., Akalu, Y., Teferi, B., Molla, M. D., & Shibabaw, T. (2020) · Journal of Asthma and Allergy · doi:10.2147/jaa.s273556 · Cited by 32
Metadata
- Authors
- Khan, A. R., & Fallon, P. G.
- Venue
- International Journal for Parasitology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 43
- Issue
- 3-4
- Pages
- 293-299
- ISSN
- 0020-7519 (ISSN-L)
- OpenAlex
- W2105908328
- Cited by
- 73
- References
- 6
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Helminth therapies: Translating the unknown unknowns to known knowns. https://app.cochat.ai/papers/10.1016/j.ijpara.2012.12.002
- The paper
- Khan, A. R., & Fallon, P. G. (2013). Helminth therapies: Translating the unknown unknowns to known knowns. International Journal for Parasitology. https://doi.org/10.1016/j.ijpara.2012.12.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.